Wave Life Sciences Ltd.WVENASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -6.81% |
| Q2 2025 | -5.93% |
| Q1 2025 | -316.85% |
| Q4 2024 | 135.93% |
| Q3 2024 | -82.63% |
| Q2 2024 | -1.56% |
| Q1 2024 | -84.44% |
| Q4 2023 | -520.39% |
| Q3 2023 | 118.93% |
| Q2 2023 | 22.49% |
| Q1 2023 | 30.48% |
| Q4 2022 | -11.99% |
| Q3 2022 | 7.74% |
| Q2 2022 | -10.68% |
| Q1 2022 | -5.49% |
| Q4 2021 | -374.69% |
| Q3 2021 | 80.90% |
| Q2 2021 | 8.38% |
| Q1 2021 | -43.41% |
| Q4 2020 | 11.92% |
| Q3 2020 | 10.97% |
| Q2 2020 | 22.68% |
| Q1 2020 | 17.41% |
| Q4 2019 | -11.73% |
| Q3 2019 | -18.77% |
| Q2 2019 | 4.94% |
| Q1 2019 | 1.95% |
| Q4 2018 | -28.02% |
| Q3 2018 | -4.54% |
| Q2 2018 | -2.23% |
| Q1 2018 | -16.99% |
| Q4 2017 | -13.29% |
| Q3 2017 | -7.56% |
| Q2 2017 | -26.01% |
| Q1 2017 | -7.62% |
| Q4 2016 | -7.38% |
| Q3 2016 | -48.08% |
| Q2 2016 | -46.35% |
| Q1 2016 | -10.23% |
| Q4 2015 | -44.57% |